Kevin Mouillesseaux

Kevin Mouillesseaux has a diverse work experience spanning from 2001 to the present. From 2001 to 2002, they worked as a Research Assistant at The Super Shrimp Group. From 2002 to 2003, they worked as a Staff Research Associate at The Scripps Research Institute. From 2003 to 2012, they worked as a Staff Research Associate II at UCLA. From 2012 to 2015, they worked as a Postdoctoral Fellow at the University of North Carolina at Chapel Hill. In this role, they investigated signal transduction pathways and developed novel single-cell quantification assays. From 2015 to 2016, they worked as a Research Associate at Biogen, where they developed small-scale cell culture and process characterization. From 2016 to 2023, they worked at StrideBio, Inc, in various roles including Vice President of Viral Vector Development, Senior Director of Process Development, Director of Process Development, Associate Director of Process Development, and Senior Scientist. Currently, they are the Vice President of CMC at Atsena Therapeutics.

Kevin Mouillesseaux obtained a Bachelor of Science (BS) in Biology from UC San Diego between 1997 and 2001. Subsequently, they obtained a Doctor of Philosophy (PhD) in Molecular, Cell, and Developmental Biology from the University of California, Los Angeles between 2006 and 2011.